Anthony Kim | CFO |
Peter Hoang | President, CEO & Director |
Mythili Koneru | Chief Medical Officer |
Juan Vera | Chief Development Officer & Director |
Matthew Biegler | Oppenheimer |
Good afternoon, ladies and gentlemen, and welcome to the Marker Therapeutics' conference call. [Operator Instructions].
As a reminder, this conference call is being recorded. I would now like to hand the call over to Mr. Tony Kim, Chief Financial Officer, at Marker.